Kaposi's sarcoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Hudakarman (talk | contribs) |
||
(56 intermediate revisions by 10 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | |||
{{ | {{CMG}} {{AE}} {{F.K}} {{HL}} {{ADS}} {{Hudakarman}} | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Kaposi%27s_sarcoma]] | |||
==Overview== | ==Overview== | ||
Kaposi's sarcoma must be differentiated from other [[diseases]] that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement, such as [[bacillary angiomatosis]], [[AIDS]]-related [[lymphoma]], and [[seborrheic keratosis]]. | |||
==Differentiating Kaposi's | ==Differentiating Kaposi's Sarcoma from other Diseases== | ||
*''' | *Kaposi's sarcoma must be differentiated from other [[diseases]] that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement.<ref name="radio">Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016</ref><ref name="patho">Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016</ref><ref name="patho2">Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015</ref><small> | ||
{| | |||
:*[[ | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
:*[[Seborrheic | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
:*[[ | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | |||
* | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | |||
:*[[ | ! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings | ||
:*[[ | ! colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | |||
*' | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | |||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs | |||
:*[[ | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC | ||
:*[[ | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | |||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | |||
|- | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Human Immunodeficiency Virus (HIV)|HIV]] | |||
*[[Chronic lymphocytic leukemia]] | |||
* Cytotoxic [[chemotherapy]] | |||
*[[Organ transplant|Organ transplantation]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | Any age, usually between 20 -50 years | |||
| style="background:#F5F5F5;" align="center" | [[Solitary]] or multiple red, purple, flesh-colored, or colorless [[Papule|papules]] | |||
| style="background:#F5F5F5;" align="center" | ± | |||
| style="background:#F5F5F5;" align="center" | ± | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Anorexia]] | |||
*[[Weight loss]] | |||
*[[Abdominal pain]] | |||
*[[Nausea and vomiting]] | |||
*[[Headache]] | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
* Lobular vascular proliferations of [[Blood vessel|vessels]] lined by plump [[Endothelium|endothelial cells]] | |||
| style="background:#F5F5F5;" align="center" | Clinical manifestation | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Mental disorder|Psychiatric disorders]] | |||
*[[Personality|Personality changes]] | |||
*[[Seizure]] | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Idiopathic]] | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Any age | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Headache]] | |||
*[[Neurologic diseases|Neurologic deficits]] | |||
*[[Congestive heart failure|Heart failure]] | |||
*[[Macrocephaly]] | |||
| style="background:#F5F5F5;" align="center" |Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" |NA | |||
| style="background:#F5F5F5;" align="center" |[[Imaging]] | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Hereditary hemorrhagic telangiectasia]] | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acroangiodermatitis]]<ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Idiopathic]] | |||
* Hyperplasia of pre-existing vasculature | |||
*[[Hypertension|HTN]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Any age, more in males | |||
| style="background:#F5F5F5;" align="center" | Purplish-blue to brown [[Papule|papules]] and [[Plaque|plaques]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="left" | | |||
* Paralysed legs | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Hyperkeratosis]] | |||
* Parakeratosis | |||
*[[Acanthosis nigricans|Acanthosis]] | |||
* Mild spongiosis | |||
| style="background:#F5F5F5;" align="center" | Clinical manifesttations | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Amputation]] | |||
*[[Hemodialysis|Haemodialysis]] patients with [[Arteriovenous fistula|arteriovenous shunts]] | |||
*[[Hepatitis C]] | |||
*[[Venous insufficiency|Chronic venous insufficiency]] | |||
*[[Arteriovenous malformation|AV malformations]] | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Idiopathic]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Adults, more in males | |||
| style="background:#F5F5F5;" align="center" |Enlarging [[bruise]], a blue-black [[Nodule (medicine)|nodule]], or an unhealed [[Ulcer|ulceration]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | ↓ | |||
| style="background:#F5F5F5;" align="center" | ↓ | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
* Intercellular and intracellular lumina with or without [[Red blood cell|red cells]] | |||
* Intermediate filaments and pinocytotic vesicles in [[cytoplasm]] | |||
*[[Weibel-Palade body|Weibel-Palade bodies]] | |||
| style="background:#F5F5F5;" align="center" |[[Biopsy]] | |||
| style="background:#F5F5F5;" align="center" |NA | |||
|- | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Idiopathic]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" |Rare | |||
| style="background:#F5F5F5;" align="left" | | |||
* Normal | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
* Papillary fronds lined by proliferating [[endothelium]] | |||
| style="background:#F5F5F5;" align="center" |[[Biopsy]] | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Hemangioma]] | |||
*[[Pyogenic granuloma|Pyogenic granulomas]] | |||
*[[Lymphangioma overview|Lymphangiomas]] | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
* Clonal expansion of a mutated epidermal [[keratinocyte]] | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Any age | |||
| style="background:#F5F5F5;" align="left" | | |||
* Usually [[asymptomatic]] | |||
* Being stuck on the skin surface | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
* Papillomatous epithelial proliferation containing horn [[Cyst|cysts]] | |||
| style="background:#F5F5F5;" align="center" | Clinical manifestations | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Dermatosis papulosa nigra]] | |||
* Stucco keratosis | |||
* Melanoacanthoma | |||
* Polypoid lesions | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Idiopathic]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | More common in female, typically in the 20 to 30 years | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Erythema]] on the [[Mouth|nasolabial folds]] | |||
*[[Macule|Macular]] or diffusely erythematous in sun-exposed areas | |||
* Discoid rash | |||
| style="background:#F5F5F5;" align="center" | ± | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | ↑ | |||
| style="background:#F5F5F5;" align="center" | ± | |||
| style="background:#F5F5F5;" align="center" | ± | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Weight loss]] | |||
*[[Headache]] | |||
*[[Arthralgia]] | |||
*[[Myalgia]] | |||
*[[Nausea and vomiting|Nausea]] | |||
*[[Dyspepsia]] | |||
*[[Pleuritic chest pain]] | |||
*[[Dyspnea]] | |||
*[[Hematuria]] | |||
| style="background:#F5F5F5;" align="center" | ↑ | |||
| style="background:#F5F5F5;" align="center" | ↓ | |||
| style="background:#F5F5F5;" align="center" | ↓ | |||
| style="background:#F5F5F5;" align="center" |Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Hyperkeratosis]], epidermal [[atrophy]], vacuolar interface [[dermatitis]] | |||
* Thickening of the [[basement membrane]] | |||
* Superficial, [[Perivascular cell|perivascular]], and perifollicular [[Monocyte|mononuclear cell]] inflammatory infiltrate | |||
| style="background:#F5F5F5;" align="center" | Clinical manifestations | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Raynaud's phenomenon|Raynaud phenomenon]] | |||
*[[Neuropsychiatry|Neuropsychiatric]] symptoms | |||
*[[Pleural effusion]] | |||
*[[Peptic ulcer|Peptic ulcer disease]] | |||
*[[Pericarditis]] | |||
*[[Myocarditis]] | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyogenic]] granuloma <ref name="pmid22434943">{{cite journal |vauthors=Kamal R, Dahiya P, Puri A |title=Oral pyogenic granuloma: Various concepts of etiopathogenesis |journal=J Oral Maxillofac Pathol |volume=16 |issue=1 |pages=79–82 |date=January 2012 |pmid=22434943 |pmc=3303528 |doi=10.4103/0973-029X.92978 |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Physical trauma|Trauma]] | |||
* Hormonal influences | |||
*[[Virus|Viruses]] | |||
* Cytogenetic clonal deletion abnormalities | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years | |||
| style="background:#F5F5F5;" align="left" | | |||
* Painless red lesion | |||
* Lobular [[capillary hemangioma]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
* Neutrophilic infiltration | |||
*[[Bleeding|Hemorrhage]] | |||
*[[Necrosis]] of the overlying [[Epidermis (skin)|epidermis]] | |||
| style="background:#F5F5F5;" align="center" | Clinical manifestation | |||
| style="background:#F5F5F5;" align="center" |NA | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Idiopathic]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | + | |||
| style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years | |||
| style="background:#F5F5F5;" align="left" | | |||
* single, slowly expanding patch, [[plaque]], or [[Nodule (medicine)|nodule]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
* Thin-walled endothelial-lined spaces that are interspersed between strands of [[collagen]] | |||
| style="background:#F5F5F5;" align="center" |[[Biopsy]] | |||
| style="background:#F5F5F5;" align="center" |NA | |||
|- | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref> | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Idiopathic]] | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Usually in third to fifth decades of life. | |||
| style="background:#F5F5F5;" align="left" | | |||
* Painless, slowly progressive protrusion or bulging of their globe | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | – | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="center" | Nl | |||
| style="background:#F5F5F5;" align="left" | | |||
* Engorged vascular channels, which are tightly knit and separated by [[Fiber|fibrous]] septae | |||
| style="background:#F5F5F5;" align="center" | Clinical manidestation | |||
| style="background:#F5F5F5;" align="left" | | |||
*[[Diplopia]] | |||
* Decreased [[color vision]] | |||
*[[Visual field loss|Visual field deficits]] | |||
|- | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | |||
|} | |||
</small> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:HIV/AIDS]] | [[Category:HIV/AIDS]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Vascular medicine]] | |||
[[Category:Surgery]] |
Latest revision as of 15:18, 10 October 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Haytham Allaham, M.D. [3] Amandeep Singh M.D.[4] Huda A. Karman, M.D.
Overview
Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement, such as bacillary angiomatosis, AIDS-related lymphoma, and seborrheic keratosis.
Differentiating Kaposi's Sarcoma from other Diseases
- Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement.[1][2][3]
Diseases | Etiology | Congenital | Acquired | Demography | Clinical manifestations | Lab findings | Gold standard diagnosis | Associated findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | CBC | LFT | ESR/CRP | Histopathology | ||||||||||||||
Appearance | Fever | Bleeding | BP | Hepatosplenomegaly | Lymphadenopathy | Other | WBC | Hb | Plt | ||||||||||
Bacillary angiomatosis [4] | – | + | Any age, usually between 20 -50 years | Solitary or multiple red, purple, flesh-colored, or colorless papules | ± | ± | Nl | – | – | Nl | Nl | Nl | Nl | Nl |
|
Clinical manifestation | |||
Arteriovenous malformation [5] | + | – | Any age | Nl | – | + | Nl | – | – | Nl | Nl | Nl | Nl | Nl | NA | Imaging | |||
Acroangiodermatitis[6] |
|
– | – | Any age, more in males | Purplish-blue to brown papules and plaques | – | – | Nl | – | – |
|
Nl | Nl | Nl | Nl | Nl |
|
Clinical manifesttations | |
Angiosarcoma [7] | – | – | Adults, more in males | Enlarging bruise, a blue-black nodule, or an unhealed ulceration | – | – | Nl | – | – | – | Nl | ↓ | ↓ | Nl | Nl |
|
Biopsy | NA | |
Diseases | Etiology | Congenital | Acquired | Demography | Appearance | Fever | Bleeding | BP | Hepatosplenomegaly | Lymphadenopathy | Other | WBC | Hb | Plt | LFT | ESR/CRP | Histopathology | Gold standard diagnosis | Associated findings |
Masson's hemangioma [8] | – | – | Rare |
|
– | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl |
|
Biopsy | ||
Seborrheic keratosis [9] |
|
+ | – | Any age |
|
– | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl |
|
Clinical manifestations |
|
Systemic lupus erythematosus (SLE) [10] | – | – | More common in female, typically in the 20 to 30 years |
|
± | – | ↑ | ± | ± | ↑ | ↓ | ↓ | Nl | Nl |
|
Clinical manifestations | |||
Pyogenic granuloma [11] | + | + | Any age, usually in 20-30 years |
|
– | + | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl |
|
Clinical manifestation | NA | |
Benign lymphangioendothelioma [12] | – | + | Any ages, median age is 50 years | – | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl |
|
Biopsy | NA | ||
Cavernous hemangioma [13] | – | – | Usually in third to fifth decades of life. |
|
– | – | Nl | – | – | – | Nl | Nl | Nl | Nl | Nl |
|
Clinical manidestation |
| |
Diseases | Etiology | Congenital | Acquired | Demography | Appearance | Fever | Bleeding | BP | Hepatosplenomegaly | Lymphadenopathy | Other | WBC | Hb | Plt | LFT | ESR/CRP | Histopathology | Gold standard diagnosis | Associated findings |
References
- ↑ Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016
- ↑ Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016
- ↑ Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015
- ↑ Tappero JW, Perkins BA, Wenger JD, Berger TG (July 1995). "Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus". Clin. Microbiol. Rev. 8 (3): 440–50. PMC 174635. PMID 7553576.
- ↑ Whitehead KJ, Smith MC, Li DY (February 2013). "Arteriovenous malformations and other vascular malformation syndromes". Cold Spring Harb Perspect Med. 3 (2): a006635. doi:10.1101/cshperspect.a006635. PMC 3552339. PMID 23125071.
- ↑ Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A (2007). "Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports". Acta Dermatovenerol Croat. 15 (3): 152–7. PMID 17868541.
- ↑ Barttelbort SW, Stahl R, Ariyan S (July 1989). "Cutaneous angiosarcoma of the face and scalp". Plast. Reconstr. Surg. 84 (1): 55–9. PMID 2734404.
- ↑ Park KK, Won YS, Yang JY, Choi CS, Han KY (July 2012). "Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review". J Korean Neurosurg Soc. 52 (1): 52–4. doi:10.3340/jkns.2012.52.1.52. PMC 3440504. PMID 22993679.
- ↑ Noiles K, Vender R (2008). "Are all seborrheic keratoses benign? Review of the typical lesion and its variants". J Cutan Med Surg. 12 (5): 203–10. doi:10.2310/7750.2008.07096. PMID 18845088.
- ↑ Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P (2012). "Cutaneous manifestations of systemic lupus erythematosus". Autoimmune Dis. 2012: 834291. doi:10.1155/2012/834291. PMC 3410306. PMID 22888407.
- ↑ Kamal R, Dahiya P, Puri A (January 2012). "Oral pyogenic granuloma: Various concepts of etiopathogenesis". J Oral Maxillofac Pathol. 16 (1): 79–82. doi:10.4103/0973-029X.92978. PMC 3303528. PMID 22434943.
- ↑ Guillou L, Fletcher CD (August 2000). "Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series". Am. J. Surg. Pathol. 24 (8): 1047–57. PMID 10935645.
- ↑ Goldberg RE, Pheasant TR, Shields JA (December 1979). "Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement". Arch. Ophthalmol. 97 (12): 2321–4. PMID 229814.